Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Leber's Hereditary Optic Neuropathy (LHON)
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This study is a multicentre, prospective, non-interventional post-authorisation safety study (PASS) of the clinical outcomes for patients with LHON treated with Raxone®. No medication will be provided as part of this study. Raxone® will be obtained through commercial channels.

Provided treatments

  • Drug: Idebenone
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02771379. The sponsor of the trial is Santhera Pharmaceuticals and it is looking for 250 volunteers for the current phase.
Official trial title:
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)